These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29991058)

  • 1. Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer.
    Wang HM; Zhang XH; Feng MM; Qiao YJ; Ye LQ; Chen J; Fan FF; Guo LL
    Cell Physiol Biochem; 2018; 47(6):2407-2419. PubMed ID: 29991058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of interleukin-7 on the anti-tumor function of CD8(+) T cells in patients with non-small cell lung cancer].
    Zhang XH; Wang HM; Jin L; Chang R; Zu FC; Li FZ; Ku CY
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2429-2433. PubMed ID: 30138989
    [No Abstract]   [Full Text] [Related]  

  • 3. Insufficient CD100 shedding contributes to suppression of CD8
    Wang HM; Zhang XH; Ye LQ; Zhang K; Yang NN; Geng S; Chen J; Zhao SX; Yang KL; Fan FF
    Immunology; 2020 Jun; 160(2):209-219. PubMed ID: 32149403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Notch1 enhances interleukin-22 production by CD4
    Pang B; Hu C; Xing N; Xu L; Zhang S; Yu X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer.
    Heim L; Kachler K; Siegmund R; Trufa DI; Mittler S; Geppert CI; Friedrich J; Rieker RJ; Sirbu H; Finotto S
    Br J Cancer; 2019 Apr; 120(9):903-912. PubMed ID: 30956278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-35 suppresses antitumor activity of circulating CD8
    Liu MX; Liu QY; Liu Y; Cheng ZM; Liu L; Zhang L; Sun DH
    Connect Tissue Res; 2019 Jul; 60(4):367-375. PubMed ID: 30616389
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer.
    Song L; Ma S; Chen L; Miao L; Tao M; Liu H
    Cancer Sci; 2019 Jul; 110(7):2100-2109. PubMed ID: 31100180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution and function of human memory T cell subsets in lung cancer.
    Sheng SY; Gu Y; Lu CG; Zou JY; Hong H; Wang R
    Immunol Res; 2017 Jun; 65(3):639-650. PubMed ID: 28101811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5
    Ma QY; Huang DY; Zhang HJ; Wang S; Chen XF
    Int Immunopharmacol; 2017 Nov; 52():305-309. PubMed ID: 28982050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of CD4(+) and CD8(+) T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking.
    Jackutė J; Žemaitis M; Pranys D; Šitkauskienė B; Miliauskas S; Bajoriūnas V; Sakalauskas R
    Medicina (Kaunas); 2015 Nov; 51(5):263-71. PubMed ID: 26674143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
    Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
    Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
    Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
    Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
    Hald SM; Bremnes RM; Al-Shibli K; Al-Saad S; Andersen S; Stenvold H; Busund LT; Donnem T
    Lung Cancer; 2013 May; 80(2):209-15. PubMed ID: 23384671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
    Yu DP; Han Y; Zhao QY; Liu ZD
    Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
    Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
    Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 Promotes Antitumoral Effector Functions and Memory CD8
    Heim L; Friedrich J; Engelhardt M; Trufa DI; Geppert CI; Rieker RJ; Sirbu H; Finotto S
    Cancer Res; 2018 Jul; 78(13):3619-3633. PubMed ID: 29691251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.